• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Two Drug Combination Doubled Kidney Cancer Progression Free Survival

  • — 7 Nov, 2018
Two Drug Combination Doubled Kidney Cancer Progression Free Survival
Robert Motzer MD, New York
Audio Journal of Oncology Podcast
Audio Journal of Oncology Podcast
Two Drug Combination Doubled Kidney Cancer Progression Free Survival
Two Drug Combination Doubled Kidney Cancer Progression Free Survival
00:00 / 9 minutes
Apple Podcasts Spotify Stitcher
RSS Feed
Share
Link
Embed

Subscribe: Apple Podcasts | Spotify | Stitcher

MUNICH— A doubling of progression free survival (PFS) and objective response rate (ORR) was observed in patients who had their previously untreated advanced renal cell cancer (RCC) treated with a combination of the vascular endothelial growth factor (VEGF) inhibitor axitinib plus the anti-programmed death one ligand (PD-L1) avelumab in comparison with those receiving standard sunitinib anti-VEGF therapy in the randomized phase threeJAVELIN Renal 101 clinical trial. Findings were reported at the 2018 annual congress of the European Society for Medical Oncology (ESMO).  http://212.114.167.162/slidecenter/esmo2018/attendee/confcal/session/calendar?q=LBA6_PR

Robust PFS

“The progression free survival was so robust, the objective response rate was robust [and] the safety profile was favorable that [this] warrants this combination as a new standard of care in patients with advanced kidney cancer,”  lead investigator of the study Robert J Motzer MD PhD, a medical oncologist at Memorial Sloan-Kettering Cancer Center in New York told the Audio Journal of Oncology.

You may also like...

  • Lung Cancer Pembrolizuab Monotherapy Extended Survival in Advanced Lung Cancer 8 Jun, 2018
  • Oncology Times Broadcast News with the Audio Journal of Oncology – Insulin-Like Growth Factor Inhibition In Lung Cancer Oncology Times Broadcast News with the Audio Journal of Oncology – Insulin-Like Growth Factor Inhibition In Lung Cancer 6 Apr, 2009
  • John Yarnold Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse 11 Dec, 2012
  • Giuseppe Curigliano MD PhD, Director of the Early Drug Development for Innovative Therapies Division at the European Institute of Oncology, Milan Tumor Microenvironment: Tumor Infiltrating Lymphocyte Score Predicts Breast Cancer Outcome 27 Mar, 2015
  • Previous story ALK—Targeted Lung Cancer Drugs Benefited Real World Patients 
  • Next story Which New Combination for Metastatic Renal Cell Cancer?
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • New Front Line Standard for Older Patients with Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
  • Home
  • Oncology
  • AJO
  • Two Drug Combination Doubled Kidney Cancer Progression Free Survival

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.